Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment

J Immunol. 2009 Aug 1;183(3):1667-74. doi: 10.4049/jimmunol.0900056. Epub 2009 Jul 10.

Abstract

Fas apoptosis inhibitory molecule (FAIM) was cloned as a mediator of Fas resistance that is highly evolutionarily conserved but contains no known effector motifs. In this study, we report entirely new functions of FAIM that regulate B cell signaling and differentiation. FAIM acts to specifically enhance CD40 signaling for NF-kappaB activation, IRF-4 expression, and BCL-6 down-regulation in vitro, but has no effect on its own or in conjunction with LPS or anti-Ig stimulation. In keeping with its effects on IRF-4 and BCL-6, FAIM overexpression augments the plasma cell compartment in vivo. These results indicate that FAIM is a new player on the field of B cell differentiation and acts as a force multiplier for a series of events that begins with CD40 engagement and ends with plasma cell differentiation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Apoptosis Regulatory Proteins / physiology*
  • B-Lymphocytes
  • CD40 Antigens / metabolism*
  • Cell Proliferation
  • DNA-Binding Proteins / genetics
  • Gene Expression Regulation
  • Humans
  • Interferon Regulatory Factors / genetics
  • NF-kappa B / metabolism
  • Proto-Oncogene Proteins c-bcl-6
  • Signal Transduction

Substances

  • Apoptosis Regulatory Proteins
  • BCL6 protein, human
  • CD40 Antigens
  • DNA-Binding Proteins
  • FAIM protein, human
  • Interferon Regulatory Factors
  • NF-kappa B
  • Proto-Oncogene Proteins c-bcl-6
  • interferon regulatory factor-4